Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors

In spite of significant progress in anti-HIV-1 therapy, current antiviral chemo-therapy still suffers from deleterious side effects and emerging drug resistance. Therefore, the development of novel antiviral drugs remains a crucial issue for the fight against AIDS. HIV-1 integrase is a key enzyme in...

Full description

Bibliographic Details
Main Authors: Didier Desmaële, Jean-François Mouscadet
Format: Article
Language:English
Published: MDPI AG 2010-04-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/15/5/3048/
_version_ 1818859258764066816
author Didier Desmaële
Jean-François Mouscadet
author_facet Didier Desmaële
Jean-François Mouscadet
author_sort Didier Desmaële
collection DOAJ
description In spite of significant progress in anti-HIV-1 therapy, current antiviral chemo-therapy still suffers from deleterious side effects and emerging drug resistance. Therefore, the development of novel antiviral drugs remains a crucial issue for the fight against AIDS. HIV-1 integrase is a key enzyme in the replication cycle of the retrovirus since it catalyzes the integration of the reverse transcribed viral DNA into the chromosomal DNA. Efforts to develop anti-integrase drugs started during the early nineties, culminating with the recent approval of Raltegravir. The discovery and the development of the styrylquinoline inhibitor class was an important step in the overall process. In this review we have described the key synthetic issues and the structure-activity relationship of this family of integrase inhibitors. Crystallographic and docking studies that shed light on their mechanism of action are also examined.
first_indexed 2024-12-19T09:09:20Z
format Article
id doaj.art-d5f1d2ef090f467b991ff19ad48c6b7d
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-19T09:09:20Z
publishDate 2010-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-d5f1d2ef090f467b991ff19ad48c6b7d2022-12-21T20:28:15ZengMDPI AGMolecules1420-30492010-04-011553048307810.3390/molecules15053048Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase InhibitorsDidier DesmaëleJean-François MouscadetIn spite of significant progress in anti-HIV-1 therapy, current antiviral chemo-therapy still suffers from deleterious side effects and emerging drug resistance. Therefore, the development of novel antiviral drugs remains a crucial issue for the fight against AIDS. HIV-1 integrase is a key enzyme in the replication cycle of the retrovirus since it catalyzes the integration of the reverse transcribed viral DNA into the chromosomal DNA. Efforts to develop anti-integrase drugs started during the early nineties, culminating with the recent approval of Raltegravir. The discovery and the development of the styrylquinoline inhibitor class was an important step in the overall process. In this review we have described the key synthetic issues and the structure-activity relationship of this family of integrase inhibitors. Crystallographic and docking studies that shed light on their mechanism of action are also examined.http://www.mdpi.com/1420-3049/15/5/3048/AIDSHIV-1integraseinhibitorstyrylquinoline
spellingShingle Didier Desmaële
Jean-François Mouscadet
Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
Molecules
AIDS
HIV-1
integrase
inhibitor
styrylquinoline
title Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
title_full Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
title_fullStr Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
title_full_unstemmed Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
title_short Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
title_sort chemistry and structure activity relationship of the styrylquinoline type hiv integrase inhibitors
topic AIDS
HIV-1
integrase
inhibitor
styrylquinoline
url http://www.mdpi.com/1420-3049/15/5/3048/
work_keys_str_mv AT didierdesmaele chemistryandstructureactivityrelationshipofthestyrylquinolinetypehivintegraseinhibitors
AT jeanfrancoismouscadet chemistryandstructureactivityrelationshipofthestyrylquinolinetypehivintegraseinhibitors